JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Devedjian, J. C.
Right arrow Articles by Paris, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Devedjian, J. C.
Right arrow Articles by Paris, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 266, Issue 22, 14359-14366, 08, 1991

Regulation of the alpha 2A-adrenergic receptor in the HT29 cell line. Effects of insulin and growth factors

JC Devedjian, M Fargues, C Denis-Pouxviel, D Daviaud, H Prats and H Paris
Institut National de la Sante et de la Recherche Medicale U.317 Toulouse, France.

The density of the alpha 2A-adrenergic receptor in the HT29 cell line, a human colonic adenocarcinoma, increases when the cells are placed in fetal calf serum (FCS)-free culture medium and decreases again, in a concentration-dependent manner, when they are re-exposed to FCS. In an attempt to identify the FCS components responsible for this phenomenon, we examined the effect of insulin and of various growth factors on receptor expression. Incubation of HT29 cells with insulin resulted in a time- and dose-dependent lowering of the alpha 2-adrenergic receptor number. The decrease of [3H] RX821002 binding sites after a 48-h period of treatment reached 70-75% with 170 nM insulin, and a half-maximal effect was observed at 2.6 nM. This value is in agreement with the EC50 of the hormone for stimulating the glycolytic activity of HT29 cells (8 nM) and is sufficiently low to indicate that the decrease of alpha 2- adrenergic receptor number is mediated through stimulation of insulin receptors. Direct quantification of [3H] UK14304 binding sites and the study of the inhibition of [3H]RX821002 binding by (-)-epinephrine indicated that the degree of receptor coupling to Gi protein was not affected when the receptor number was decreased by insulin treatment. The reduction in receptor number did result in an attenuation of the inhibitory effect of UK14304 on forskolin-induced cAMP accumulation in a manner which was consistent with the existence of a large population of spare receptors in untreated cells. The action of insulin is not due to an accelerated rate of receptor degradation and can be mimicked by other growth factors (epidermal growth factor and insulin-like growth factors I and II) acting through stimulation of tyrosine kinase receptors. RNase mapping experiments with a 0.35-kilobase riboprobe prepared from the human alpha 2 C10-adrenergic receptor gene demonstrated that the decrease of receptor number induced by the different treatments is a reflection of changes occurring at the level of its mRNA. The use of cycloheximide indicated that the effect of insulin on alpha 2-adrenergic receptor mRNA does not require protein synthesis. The half-life of the alpha 2-adrenergic receptor mRNA measured after the addition of actinomycin D was unchanged by insulin which suggests that a decrease in the transcription rate is the predominant factor responsible for the observed regulation of receptor expression.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. A. Chotani, S. Mitra, B. Y. Su, S. Flavahan, A. H. Eid, K. R. Clark, C. R. Montague, H. Paris, D. E. Handy, and N. A. Flavahan
Regulation of {alpha}2-adrenoceptors in human vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H59 - H67.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Greney, D. Urosevic, S. Schann, L. Dupuy, V. Bruban, J.-D. Ehrhardt, P. Bousquet, and M. Dontenwill
[125I]2-(2-Chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a High-Affinity Radioligand Selective for I1 Imidazoline Receptors
Mol. Pharmacol., July 1, 2002; 62(1): 181 - 191.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Schaak, C. Cayla, A. Lymperopoulos, C. Flordellis, D. Cussac, C. Denis, and H. Paris
Transcriptional Down-Regulation of the Human alpha 2C-Adrenergic Receptor by cAMP
Mol. Pharmacol., October 1, 2000; 58(4): 821 - 827.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Berlioz, J.-J. Maoret, H. Paris, M. Laburthe, R. Farinotti, and C. Rozé
alpha 2-Adrenergic Receptors Stimulate Oligopeptide Transport in a Human Intestinal Cell Line
J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 466 - 472.
[Abstract] [Full Text]


Home page
GutHome page
S Schaak, D Cussac, C Cayla, J C Devedjian, R Guyot, H Paris, and C Denis
Alpha2 adrenoceptors regulate proliferation of human intestinal epithelial cells
Gut, August 1, 2000; 47(2): 242 - 250.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. C. Blaxall, A. C. Pellett, S. C. Wu, A. Pende, and J. D. Port
Purification and Characterization of beta -Adrenergic Receptor mRNA-binding Proteins
J. Biol. Chem., February 11, 2000; 275(6): 4290 - 4297.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Schaak, C. Cayla, R. Blaise, F. Quinchon, and H. Paris
HepG2 and SK-N-MC: Two Human Models to Study Alpha-2 Adrenergic Receptors of the Alpha-2C Subtype
J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 983 - 991.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1991 by the American Society for Biochemistry and Molecular Biology.